https://scholars.lib.ntu.edu.tw/handle/123456789/628061
標題: | Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study | 作者: | Heerspink, Hiddo J L Karasik, Avraham Thuresson, Marcus Melzer-Cohen, Cheli Chodick, Gabriel Khunti, Kamlesh Wilding, John P H Garcia Rodriguez, Luis Alberto Cea-Soriano, Lucia Kohsaka, Shun Nicolucci, Antonio Lucisano, Giuseppe FANG-JU LIN CHIH-YUAN WANG Wittbrodt, Eric Fenici, Peter Kosiborod, Mikhail |
公開日期: | 一月-2020 | 卷: | 8 | 期: | 1 | 來源出版物: | The lancet. Diabetes & endocrinology | 摘要: | Cardiovascular and kidney outcome trials have shown that sodium-glucose co-transporter-2 (SGLT2) inhibitors slow progression of chronic kidney disease in patients with type 2 diabetes with or without chronic kidney disease. The aim of this study was to assess whether these benefits extend to patients with type 2 diabetes treated in routine clinical practice. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/628061 | ISSN: | 22138587 | DOI: | 10.1016/S2213-8587(19)30384-5 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。